Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mingzhao Wang is active.

Publication


Featured researches published by Mingzhao Wang.


European Journal of Cancer Prevention | 2013

Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.

Dongfang Tang; Yi Shen; Mingzhao Wang; Ronghua Yang; Zizong Wang; Aihua Sui; Wenjie Jiao; Yongjie Wang

Recent diagnostic procedure advances have considerably improved early lung cancer detection. However, the invasive, unpleasant, and inconvenient nature of current diagnostic procedures limits their application. There is a great need for novel noninvasive biomarkers for early lung cancer diagnosis. In the present study, we aimed to determine whether microRNA (miRNA) blood signatures are suitable for early detection of lung cancer. Using quantitative reverse transcriptase PCR analysis, we first selected and identified three aberrant plasma expression miRNAs (miR-21, miR-145, and miR-155) in a training set of 62 patients and 60 healthy smokers to define a panel that had high diagnostic efficiency for lung cancer. Then, we validated the detective ability of this miRNA panel in a testing set of 34 malignant tumor patients, 30 patients with benign pulmonary nodules and 32 healthy smokers. In the training set, miR-21 and miR-155 showed higher plasma expression levels, whereas miR-145 showed a lower expression level in patients with malignant cancer, compared with healthy controls (P⩽0.001). The three miRNAs used in combination produced the area under receiver operating characteristic curve at 0.847, which helped distinguish lung cancer from healthy smokers with 69.4% sensitivity and 78.3% specificity. A logistic regression model with the best prediction was constructed on the basis of miR-21, miR-145, and miR-155. Validation of the miRNA panel in the testing set confirmed their diagnostic value, which yields a significant improvement over any single one. Plasma miR-21, miR-145, and miR-155 have strong potential as novel noninvasive biomarkers for early detection of lung cancer.


Clinical & Translational Oncology | 2017

Prognostic significance of immune cells in the tumor microenvironment and peripheral blood of gallbladder carcinoma patients

Y. Zhang; Cuiqing Ma; Mingzhao Wang; H. Hou; L. Cui; C. Jiang; Jianhua Sun; Xun Qu

BackgroundThe role of the interaction between tumor cells and inflammatory cells in gallbladder carcinoma (GBC) is unclear. Inflammatory cells exist in both the tumor immune microenvironment and the host peripheral blood circulatory system. In the current study, we examined the prognostic value of inflammatory cells in the tumor microenvironment and peripheral blood in patients with GBC.Methods98 patients with GBC were recruited in this retrospective study. Using immunohistochemistry, we examined tumor-infiltrating CD3+ generic T-cells, CD8+ cytotoxic T-cells, CD45RO+ memory T-cells, and CD15+ neutrophils. Peripheral venous blood samples were also collected, and absolute neutrophil count (ANC), absolute lymphocyte count (ALC) and neutrophil/lymphocyte ratio (NLR) were measured. The relationships between these variables and patient outcome were evaluated.ResultsSurvival analysis revealed that the density of CD3+ cell infiltrates in the tumor microenvironment was positively correlated with overall survival (OS) and the density of CD15+ cell infiltrates was negatively correlated with the OS. The combined analysis showed that a high density of CD3+ cell infiltrates combined with a low density of CD15+ cell infiltrates was an independent prognostic factor for GBC. In peripheral blood, survival analysis suggested that ANC and NLR were negatively correlated, while ALC was positively correlated with OS. Multivariate survival analysis showed that NLR was an independent prognostic factor for gallbladder cancer prognosis.ConclusionsThe results indicate that the combination of high density of CD3+ cell infiltrates combined with a low density of CD15+ cell infiltrates in tumor samples and pretreatment peripheral blood NLR were independent prognostic factors in patients with GBC.


Indian Journal of Cancer | 2014

A modified method using a two-port approach for accessing the hilar vasculature without transferring an endostapler from camera port to utility port during thoracoscopic right upper lobectomy

Wenjie Jiao; Yandong Zhao; Y Xuan; Mingzhao Wang

For thoracoscopic upper lobectomies, most cutting endostaplers must be inserted through the camera port when using a two-port approach. Access to the hilar vasculature through only the utility port remains a challenge. In this study, we describe a procedure to access the hilar vasculature without transferring the endostapler site during a thoracoscopic right upper lobectomy. A 2.5-cm utility anterior incision was made in the fourth intercostal space. The posterior mediastinal visceral pleura were dissected to expose the posterior portion of the right upper bronchus and the anterior trunk of the right pulmonary artery. The pleura over the right hilar vasculature were then peeled with an electrocoagulation hook. The anterior trunk of the right pulmonary artery was then transected with a cutting endostapler through the utility port firstly. This crucial maneuver allowed the endostapler access to the right upper lobe pulmonary vein. The hilar structures were then easily handled in turn. This novel technique was performed successfully in 32 patients, with no perioperative deaths. The average operation time was 120.6 min (range 75-180 min). This novel technique permits effective control of the hilar vessels through the utility port, enabling simple, safe, quick and effective resection.


Indian Journal of Cancer | 2014

A retrospective study of diaphragmatic motion, pulmonary function, and quality-of-life following video-assisted thoracoscopic lobectomy in patients with nonsmall cell lung cancer

Wenjie Jiao; Yandong Zhao; Mingzhao Wang; Z Wang; R. Yang; Yuanyong Wang; Y Luo; Yi Shen

BACKGROUND Diaphragmatic dysfunction and its negative physiologic disadvantages are less commonly reported in patients with lung cancer video-assisted thoracoscopic lobectomy. The aim of this study was to investigate the outcomes of this complication on pulmonary function and quality-of-life in patients following video-assisted thoracoscopic lobectomy. OBJECTIVES The aim of this study was to investigate potential benefits on pulmonary function and quality-of-life with normal diaphragmatic motion. MATERIALS AND METHODS A retrospective study was conducted in 64 patients with nonsmall cell lung cancer after video-assisted thoracoscopic lobectomy. The population were divided into groups 1 (with diaphragmatic paralysis, n = 32) and group 2 (without diaphragmatic paralysis, n = 32) according diaphragmatic motion after postoperatively 6 months. And then, we investigated the difference between the two groups on pulmonary function and quality-of-life. RESULTS (1) At 6 months after resection, the patients in group 1 had lost 25% of their preoperative forced expiratory volume in the 1 s (FEV 1 ) (P < 0.001), and the patients in group 2 had lost 15% of their preoperative FEV 1 (P < 0.001). And the other spirometric variables in group 1 were significantly worse than that of group 2 (P < 0.001). (2) The most frequently reported postoperative symptoms were fatigue, coughing, dyspnea, and thoracotomy pain in two groups. Of all the symptom scales, only the dyspnea scale showed a significant difference which subject has a higher proportion and scale compared to control. CONCLUSIONS The present study indicates that unilateral diaphragmatic paralysis following video-assisted thoracoscopic lobectomy caused adverse effects on postoperative pulmonary function and quality-of-life.


Medical Oncology | 2013

microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation

Yi Shen; Dongfang Tang; Ruyong Yao; Mingzhao Wang; Yongjie Wang; Yasai Yao; Xiaoxiao Li; Haiping Zhang


Clinical & Translational Oncology | 2013

CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer

Wenjie Jiao; Jinpeng Zhao; Mingzhao Wang; Yuanyong Wang; Y Luo; Yandong Zhao; Dongfang Tang; Yi Shen


Clinical & Translational Oncology | 2014

Identification of the methylation of p14ARF promoter as a novel non-invasive biomarker for early detection of lung cancer

L. Li; Yi Shen; Mingzhao Wang; Dongfang Tang; Y Luo; Wenjie Jiao; Z Wang; R. Yang; K. Tian


Clinical & Translational Oncology | 2013

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib

Yuanyong Wang; Dongfang Tang; A. Sui; Wenjie Jiao; Y Luo; Mingzhao Wang; R. Yang; Z. Wang; Yi Shen


Medical Oncology | 2013

Prospective validation of quantitative NSE mRNA in pleural fluid of non-small cell lung cancer patients

Dongfang Tang; Mingzhao Wang; Aihua Sui; Yongjie Wang; Ronghua Yang; Zizong Wang; Yandong Zhao; Wenjie Jiao; Yi Shen


Indian Journal of Cancer | 2014

A new technique for dissection of the vessels simultaneously

Y Xuan; Z Wang; Mingzhao Wang; Y Luo; Wenjie Jiao

Collaboration


Dive into the Mingzhao Wang's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Y Luo

Qingdao University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge